166 related articles for article (PubMed ID: 8345720)
1. [Expression of HLA class II antigen-associated invariant chain on renal cell cancer].
Saito T; Tomita Y; Kimura M; Nishiyama T; Sato S
Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1036-40. PubMed ID: 8345720
[TBL] [Abstract][Full Text] [Related]
2. [Major histocompatibility complex class II antigens on renal cell cancer--immunohistochemical study and effect on their expression by interferon].
Tomita Y
Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1079-86. PubMed ID: 2120500
[TBL] [Abstract][Full Text] [Related]
3. MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.
Saito T; Kimura M; Kawasaki T; Sato S; Tomita Y
Cancer Lett; 1996 Dec; 109(1-2):15-21. PubMed ID: 9020898
[TBL] [Abstract][Full Text] [Related]
4. MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.
Saito T; Kimura M; Kawasaki T; Sato S; Tomita Y
Cancer Lett; 1997 May; 115(1):121-7. PubMed ID: 9097987
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
6. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
7. [Expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 (ICAM-1) on renal cell cancer. De novo expression and modulation by cytokines on renal cell cancer cell lines].
Tomita Y; Nishiyama T; Sato S; Fujiwara M
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):232-8. PubMed ID: 1674973
[TBL] [Abstract][Full Text] [Related]
8. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
[TBL] [Abstract][Full Text] [Related]
9. [Immunological study on renal cell carcinoma in dialysis patients with acquired cystic disease of kidneys].
Onishi T; Machida T; Masuda F; Torii S; Shirakawa H; Hatano T; Makino H
Nihon Hinyokika Gakkai Zasshi; 1991 Nov; 82(11):1800-6. PubMed ID: 1762269
[TBL] [Abstract][Full Text] [Related]
10. HLA class I and II antigens expression in patients with renal cell carcinoma.
Ozgur BC; Gonenc F; Yazicioglu AH
Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):97-101. PubMed ID: 19112225
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic markers in renal cell carcinoma.
Banner BF; Burnham JA; Bahnson RR; Ernstoff MS; Auerbach HE
Mod Pathol; 1990 Mar; 3(2):129-34. PubMed ID: 1691492
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
13. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
Brasanac D; Müller CA; Müller GA; Hadzi-Dzokic J; Markovic-Lipkovski J
J Exp Clin Cancer Res; 1999 Dec; 18(4):505-10. PubMed ID: 10746977
[TBL] [Abstract][Full Text] [Related]
14. Immunomorphological characteristics of renal cell carcinoma.
Markovic-Lipkovski J; Brasanac D; Todorovic V; Müller CA; Müller GA
Histol Histopathol; 1995 Jul; 10(3):651-9. PubMed ID: 7579814
[TBL] [Abstract][Full Text] [Related]
15. Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers.
Menard LC; Fischer P; Kakrecha B; Linsley PS; Wambre E; Liu MC; Rust BJ; Lee D; Penhallow B; Manjarrez Orduno N; Nadler SG
Front Immunol; 2018; 9():2728. PubMed ID: 30534127
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas.
Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R
Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998
[TBL] [Abstract][Full Text] [Related]
17. Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Dengjel J; Nastke MD; Gouttefangeas C; Gitsioudis G; Schoor O; Altenberend F; Müller M; Krämer B; Missiou A; Sauter M; Hennenlotter J; Wernet D; Stenzl A; Rammensee HG; Klingel K; Stevanović S
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4163-70. PubMed ID: 16857787
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell Carcinoma.
Miura Y; Anami T; Yatsuda J; Motoshima T; Oka S; Suyama K; Inoshita N; Kinowaki K; Urakami S; Kamba T; Komohara Y
Anticancer Res; 2021 Jun; 41(6):2841-2848. PubMed ID: 34083274
[TBL] [Abstract][Full Text] [Related]
20. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]